Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: A NeuPSIG systematic review, Delphi survey, and expert panel recommendations

Oliver Van Hecke, Peter R. Kamerman, Nadine Attal, Ralf Baron, Gyda Bjornsdottir, David L H Bennett, Michael I. Bennett, Didier Bouhassira, Luda Diatchenko, Roy Freeman, Rainer Freynhagen, Maija Haanpää, Troels S. Jensen, Srinivasa Naga Raja, Andrew S C Rice, Ze'Ev Seltzer, Thorgeir E. Thorgeirsson, David Yarnitsky, Blair H. Smith

Research output: Contribution to journalArticle

Abstract

For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies. Consensus was achieved through a staged approach: (1) systematic literature review to identify all neuropathic pain phenotypes used in previous genetic studies; (2) Delphi survey to identify the most useful neuropathic pain phenotypes and their validity and feasibility; and (3) meeting of experts to reach consensus on the optimal phenotype(s) to be collected from patients with neuropathic pain for genetic studies. A basic "entry level" set of phenotypes was identified for any genetic study of neuropathic pain. This set identifies cases of "possible" neuropathic pain, and controls, and includes: (1) a validated symptom-based questionnaire to determine whether any pain is likely to be neuropathic; (2) body chart or checklist to identify whether the area of pain distribution is neuroanatomically logical; and (3) details of pain history (intensity, duration, any formal diagnosis). This NeuroPPIC "entry level" set of phenotypes can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.

Original languageEnglish (US)
Pages (from-to)2337-2353
Number of pages17
JournalPain
Volume156
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Neuralgia
Consensus
Phenotype
Pain
Genetic Research
Surveys and Questionnaires
Checklist
Sample Size
Case-Control Studies
Guidelines

Keywords

  • Delphi survey
  • Genetics
  • Neuropathic pain
  • Phenotype
  • Systematic review

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology

Cite this

Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies : A NeuPSIG systematic review, Delphi survey, and expert panel recommendations. / Van Hecke, Oliver; Kamerman, Peter R.; Attal, Nadine; Baron, Ralf; Bjornsdottir, Gyda; Bennett, David L H; Bennett, Michael I.; Bouhassira, Didier; Diatchenko, Luda; Freeman, Roy; Freynhagen, Rainer; Haanpää, Maija; Jensen, Troels S.; Raja, Srinivasa Naga; Rice, Andrew S C; Seltzer, Ze'Ev; Thorgeirsson, Thorgeir E.; Yarnitsky, David; Smith, Blair H.

In: Pain, Vol. 156, No. 11, 01.11.2015, p. 2337-2353.

Research output: Contribution to journalArticle

Van Hecke, O, Kamerman, PR, Attal, N, Baron, R, Bjornsdottir, G, Bennett, DLH, Bennett, MI, Bouhassira, D, Diatchenko, L, Freeman, R, Freynhagen, R, Haanpää, M, Jensen, TS, Raja, SN, Rice, ASC, Seltzer, ZE, Thorgeirsson, TE, Yarnitsky, D & Smith, BH 2015, 'Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: A NeuPSIG systematic review, Delphi survey, and expert panel recommendations', Pain, vol. 156, no. 11, pp. 2337-2353. https://doi.org/10.1097/j.pain.0000000000000335
Van Hecke, Oliver ; Kamerman, Peter R. ; Attal, Nadine ; Baron, Ralf ; Bjornsdottir, Gyda ; Bennett, David L H ; Bennett, Michael I. ; Bouhassira, Didier ; Diatchenko, Luda ; Freeman, Roy ; Freynhagen, Rainer ; Haanpää, Maija ; Jensen, Troels S. ; Raja, Srinivasa Naga ; Rice, Andrew S C ; Seltzer, Ze'Ev ; Thorgeirsson, Thorgeir E. ; Yarnitsky, David ; Smith, Blair H. / Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies : A NeuPSIG systematic review, Delphi survey, and expert panel recommendations. In: Pain. 2015 ; Vol. 156, No. 11. pp. 2337-2353.
@article{03a6e37f614e419788e4f63c41e0420c,
title = "Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: A NeuPSIG systematic review, Delphi survey, and expert panel recommendations",
abstract = "For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies. Consensus was achieved through a staged approach: (1) systematic literature review to identify all neuropathic pain phenotypes used in previous genetic studies; (2) Delphi survey to identify the most useful neuropathic pain phenotypes and their validity and feasibility; and (3) meeting of experts to reach consensus on the optimal phenotype(s) to be collected from patients with neuropathic pain for genetic studies. A basic {"}entry level{"} set of phenotypes was identified for any genetic study of neuropathic pain. This set identifies cases of {"}possible{"} neuropathic pain, and controls, and includes: (1) a validated symptom-based questionnaire to determine whether any pain is likely to be neuropathic; (2) body chart or checklist to identify whether the area of pain distribution is neuroanatomically logical; and (3) details of pain history (intensity, duration, any formal diagnosis). This NeuroPPIC {"}entry level{"} set of phenotypes can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.",
keywords = "Delphi survey, Genetics, Neuropathic pain, Phenotype, Systematic review",
author = "{Van Hecke}, Oliver and Kamerman, {Peter R.} and Nadine Attal and Ralf Baron and Gyda Bjornsdottir and Bennett, {David L H} and Bennett, {Michael I.} and Didier Bouhassira and Luda Diatchenko and Roy Freeman and Rainer Freynhagen and Maija Haanp{\"a}{\"a} and Jensen, {Troels S.} and Raja, {Srinivasa Naga} and Rice, {Andrew S C} and Ze'Ev Seltzer and Thorgeirsson, {Thorgeir E.} and David Yarnitsky and Smith, {Blair H.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1097/j.pain.0000000000000335",
language = "English (US)",
volume = "156",
pages = "2337--2353",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies

T2 - A NeuPSIG systematic review, Delphi survey, and expert panel recommendations

AU - Van Hecke, Oliver

AU - Kamerman, Peter R.

AU - Attal, Nadine

AU - Baron, Ralf

AU - Bjornsdottir, Gyda

AU - Bennett, David L H

AU - Bennett, Michael I.

AU - Bouhassira, Didier

AU - Diatchenko, Luda

AU - Freeman, Roy

AU - Freynhagen, Rainer

AU - Haanpää, Maija

AU - Jensen, Troels S.

AU - Raja, Srinivasa Naga

AU - Rice, Andrew S C

AU - Seltzer, Ze'Ev

AU - Thorgeirsson, Thorgeir E.

AU - Yarnitsky, David

AU - Smith, Blair H.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies. Consensus was achieved through a staged approach: (1) systematic literature review to identify all neuropathic pain phenotypes used in previous genetic studies; (2) Delphi survey to identify the most useful neuropathic pain phenotypes and their validity and feasibility; and (3) meeting of experts to reach consensus on the optimal phenotype(s) to be collected from patients with neuropathic pain for genetic studies. A basic "entry level" set of phenotypes was identified for any genetic study of neuropathic pain. This set identifies cases of "possible" neuropathic pain, and controls, and includes: (1) a validated symptom-based questionnaire to determine whether any pain is likely to be neuropathic; (2) body chart or checklist to identify whether the area of pain distribution is neuroanatomically logical; and (3) details of pain history (intensity, duration, any formal diagnosis). This NeuroPPIC "entry level" set of phenotypes can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.

AB - For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies. Consensus was achieved through a staged approach: (1) systematic literature review to identify all neuropathic pain phenotypes used in previous genetic studies; (2) Delphi survey to identify the most useful neuropathic pain phenotypes and their validity and feasibility; and (3) meeting of experts to reach consensus on the optimal phenotype(s) to be collected from patients with neuropathic pain for genetic studies. A basic "entry level" set of phenotypes was identified for any genetic study of neuropathic pain. This set identifies cases of "possible" neuropathic pain, and controls, and includes: (1) a validated symptom-based questionnaire to determine whether any pain is likely to be neuropathic; (2) body chart or checklist to identify whether the area of pain distribution is neuroanatomically logical; and (3) details of pain history (intensity, duration, any formal diagnosis). This NeuroPPIC "entry level" set of phenotypes can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.

KW - Delphi survey

KW - Genetics

KW - Neuropathic pain

KW - Phenotype

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84951781236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951781236&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000000335

DO - 10.1097/j.pain.0000000000000335

M3 - Article

C2 - 26469320

AN - SCOPUS:84951781236

VL - 156

SP - 2337

EP - 2353

JO - Pain

JF - Pain

SN - 0304-3959

IS - 11

ER -